Newamsterdam Pharma Co N.V. (NAMS)

Last Year

26-Nov-23 -- 25-Nov-24

Time Period:

$276.22K Net Amount

Buy:	$276.22K	$19.00 - $21.50
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Accumulate

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

4

0

1

+1

0

+2

1

+3

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
01-Oct-24 5:23 PM View:	01-Oct-24 Option Sale ($707.40K)	Kooij Louise Frederika Chief Accounting Officer		Newamsterdam Pharma Co N.V. - NAMS	0% 45.0K	0	0	--	--	Show Txns Hide Txns

22-Aug-24 4:30 PM View:	20-Aug-24 Private Purchase $81.35K	Davidson Michael H. Chief Executive Officer Director		Newamsterdam Pharma Co N.V. - NAMS	1% 808.56K to 818.56K	0	0	--	--	Show Txns Hide Txns

21-Feb-24 5:00 PM View:	13-Feb-24 Market Purchase $95.00K	Lange Louis G Director		Newamsterdam Pharma Co N.V. - NAMS	25% 19.88K to 24.88K	$95.00K 25%	0	$19.00	--	Show Txns Hide Txns

28-Mar-24 4:30 PM View:	26-Mar-24 Market Purchase $181.22K	Topper James N Director		Newamsterdam Pharma Co N.V. - NAMS	0% 6.8M to 6.81M	$181.22K	0	$21.50	--	Show Txns Hide Txns

27-Mar-24 4:30 PM View:	26-Mar-24 Option Sale ($4.10M)	Kastelein Johannes Jacob Pi... Chief Scientific Officer Director		Newamsterdam Pharma Co N.V. - NAMS	0% --	0	0	--	--	Show Txns Hide Txns

19-Nov-24 4:15 PM View:	18-Nov-24 Sale (Planned) ($834.44K)	Forgrowth Nap B.V. 10% Owner		Newamsterdam Pharma Co N.V. - NAMS	0% 11.83M to 11.78M	0	0	--	--	Show Txns Hide Txns

30-Sep-24 5:22 PM View:	26-Sep-24 Private Purchase $17.33K	Audet Juliette Berangere Chief Business Officer		Newamsterdam Pharma Co N.V. - NAMS	100% 0 to 1.1K	0	0	--	--	Show Txns Hide Txns